Introduction {#Sec1}
============

D-dimer is routinely measured to exclude a diagnosis of venous thromboembolism (VTE) ([@CR1]) and is the main biomarker of VTE ([@CR2]). Appropriate age-adjusted D-dimer testing improves D-dimer specificity ([@CR3]), and could decrease inappropriate CT pulmonary angiograms (CTPA) in the older person ([@CR4], [@CR5]), thus preventing unnecessary radiation exposure. Age-adjusted D-dimer is defined as; age × 10*µ*g/l, in patients 50 years or over ([@CR6]).

Recent European Society of Cardiology (ESC) guidelines ([@CR7]) highlight the shortcomings of D-dimer testing with a low positive predictive value given that it rises in malignancy, inflammation, and hospitalised patients. The ESC endorse standardised clinical probability assessment, D-dimer testing and CTPA where appropriate.

A "COVID-19 blood battery" (CBB), is designed to efficiently evaluate and stratify suspected COVID-19 cases in our University teaching hospital (Table [1](#Tab1){ref-type="table"}). It includes D-dimers which are elevated in COVID-19 infection and potentially an index of severe infection ([@CR8]). Coagulopathy associated with COVID-19 infection is described ([@CR9]) and thrombotic complications are common, especially in critically ill ICU patients with COVID-19 ([@CR10], [@CR11]). Table 1"COVID-19 blood battery" for routine workup of COVID-19• Haematology○ Full Blood Count○ Coagulation Screen○ D-Dimer○ Ferritin• Biochemistry○ Urea and Electrolytes○ Liver Function Tests○ Lactate Dehydrogenase○ Magnesium○ Calcium profile○ Phosphate○ C Reactive Protein○ Inorganic Phosphate○ Uric Acid○ Total protein, Albumin○ Creatine Kinase○ Interleukin 6○ Procalcitonin○ Pro BNP/Troponin depending on clinical presentation○ Beta HCG in women of childbearing age• Microbiology○ Blood Cultures• ABG if hypoxic• VBG for lactate

The authors describe 3 patients with initially suspected CO VID-19 infection. All patients were admitted via the emergency department (ED), triaged as suspected CO VID-19 cases, and transferred to a COVID-19 assessment ward. Wells score (WS) ([@CR12]) was not evident in the medical notes. COVID-19 was not detected, and they were subsequently transferred to an acute geriatric ward specifically designated to manage older patients (\>75 years) with negative nasopharyngeal swab results. All were diagnosed and treated for pathologies to account for their presentations to the ED, however in addition, all had unexpectedly elevated D-dimer levels on their CBB. This was followed by CTPA performed when there was no clinical improvement with preceding treatment. Pulmonary emboli (PE) with large clot burden and evidence of right heart strain were then confirmed. Written informed consent for publication of their clinical details was obtained from each patient.

Case Histories {#Sec2}
==============

Case A {#Sec3}
------

An 89-year-old female nursing home resident was feeling generally unwell for 8 days and attended the ED following a temperature spike (38° C) on 22nd March. In the ambulance to ED, she desaturated to 80%. Heart rate at that time was 60 beats/minute, respiratory rate (RR) was 22/minute and blood pressure (BP) 112/70 mmHg. She denied any chest pain, dyspnoea, or palpitations. Her white cell count (WCC) was 22×10^9^/L with neutrophilia, and C Reactive Protein (CRP) was 126 mg/L. Her lymphocyte count was normal and her chest x-ray (CXR) was reported as demonstrating no focal infiltrates. Prothrombin Time (PT) was prolonged at 13 seconds and Activated Partial Thromboplastin Time (APTT) was reduced at 21.8 seconds and fibrinogen level was raised at 5.4 g/L. She was treated with IV antibiotics but, despite resolution of pyrexia, reduction of WCC and CRP, she continued to complain of lassitude, weakness and tiredness. A D-dimer initially performed in her CBB was 2655 *µ*g/1. In view of this and lack of clinical progress, a CTPA was performed which showed significant bilateral pulmonary emboli with a right sided infarct and reversal of blood flow noted in the hepatic inferior vena cava (IVC) indicative of right heart strain. If calculated in ED, her WS was estimated as 0. Echocardiogram revealed raised Pulmonary Arterial Pressure (PAP) at 48 mmHg. Her Charlson Comorbidity Index(CCI) ([@CR13]) score was 6 points and Clinical Frailty Scale (CFS) ([@CR14]) score was 7.

Case B {#Sec4}
------

An 88-year-old lady was unwell for 6 days and attended the ED on 14th April due to an episode of light-headedness. In the ambulance to ED, she desaturated to 82%. The patient had a known background of pulmonary hypertension for which she was on long term home oxygen therapy at a rate of 1L/min. On admission, she had an increased oxygen requirement of 3 L/min. Her WCC was 12.4 × 10^9^/L with lymphocyte count reduced to 0.7 × 10^9^/L, neutrophilia and CRP was 66 mg/L. Her proBNP level was 6580 ng/L and her coagulation screen showed PT prolonged to 13.1 seconds and normal APTT and fibrinogen levels. D-dimer initially performed in her CBB was 4049 µg/1. Her CXR showed a 6 cm inflammatory infiltrate in the right lower zone and she was treated with IV antibiotics and IV diuretics. If calculated in ED, her WS was estimated at 0. Due to persisting weakness and lassitude and the raised D-dimer, a clinical decision was made to perform a CTPA, which showed right main pulmonary artery embolism with gross dilatation of the right atrium and ventricle. Echocardiogram revealed raised PAP at 53 mmHg. Her CCI score was 4 points and CFS score was 6.

Case C {#Sec5}
------

A 76-year-old lady was feeling unwell with sweating and weakness for 10 days and attended the ED on 21st April following an episode of pre-syncope consistent with symptoms of orthostatic hypotension. She had evidence of mild delirium against a background of excellent cognition. In the ambulance to ED, she desaturated to 84%. Her CXR in the emergency department showed no clear consolidation. She had severe kyphoscoliosis. Her WCC was 14.2 × 10^9^/L with reduced lymphocyte count of 0.9 × 10^9^/L, neutrophilia, and CRP was 24 mg/L. Her coagulation screen was within the normal range. Troponin T was raised at 165 ng/L with a further increase to 277 ng/L 6 hours later and she was treated for acute coronary syndrome. She was also treated with IV antibiotics and transferred to the ward. If calculated in ED, her WS was estimated at 1.5 points (heart rate 105/min). D-dimer initially performed in her CBB was \> 10,000 *µ*g/1. Because of the grossly elevated level and, crucially, based on the results of Cases A and B, a CTPA was performed which showed bilateral pulmonary emboli with reversal of blood flow noted in the hepatic IVC indicative of right heart strain. Echocardiogram revealed PAP estimated at 38 mmHg (assuming that the right atrial pressure was 5 mmHg) but the right side of the heart was poorly visualised. Her CCI score was 3 points and CFS score was 7.

All 3 patients were treated with subcutaneous low molecular weight heparin followed by direct oral anticoagulant under the supervision of the Haematology team and made a good recovery with discharge from hospital following return to baseline.

Discussion {#Sec6}
==========

Older people are more vulnerable to poor outcomes from COVID-19 infection ([@CR15]), and are currently appropriately assessed regarding the possibility of COVID-19 infection in the ED. These very frail patients were delayed in reporting of symptoms, were all acutely but non-specifically unwell, had a high prevalence of comorbidities and transferred by ambulance to the ED. They were triaged to the COVID-19 pathway of our hospital, were assessed with a CBB and subsequently had negative COVID-19 swabs. All had an incidental finding of markedly elevated D-dimers and had potential causes of their symptoms other that PE. The WS was not documented in any of the medical case notes, supporting a lack of suspicion for PE on their initial presentation to the ED, and scores were low on retrospective estimation. They were all diagnosed with extensive PE on CTPA, (prompted by the markedly elevated D-dimer levels) with evidence of right-sided cardiac strain on CTPA and/or echocardiogram.

Markedly elevated D-dimer results are common amongst COVID-19 non-survivors and markers of severity of the inflammatory response ([@CR16]). The hospital's innovative CBB including D-dimer testing is designed to efficiently evaluate and stratify suspected COVID-19 cases.

One of the reported patients (case B) had light-headedness and another had pre-syncope which was posture-related (case C). A PE can present with syncope, with varying estimates of its prevalence from 17% of selected hospitalised patients with first presentation of syncope in a prospective study to 0.15--2.1% of hospitalised patients in a large retrospective study ([@CR17], [@CR18]). Neither of these patients had a history (or collateral history) of actual syncope nor had there been specific symptoms or signs of VTE. These non-specific symptoms would not represent an indication to pursue a diagnosis of PE in our opinion.

What are the implications of the diagnosis of an extensive PE causing right heart strain in these very frail older patients, mainly arising from a markedly elevated D-dimer level identified as part of an agreed battery of tests performed on all COVID-19 infection suspects in our institution? There are 2 possibilities. Firstly, given that false negative nasopharyngeal COVID-19 swabs can occur in up to 40% of cases ([@CR19]) it is possible that these 3 patients had relatively mild COVID-19 infections which is known to be associated with prothrombotic tendency in patients affected by severe infections resulting in ICU admission ([@CR9]--[@CR11]). All had prolonged mild and non-specific symptoms prior to admission, and thus could potentially have small viral loads with minimal contamination of nasopharyngeal areas, while having some indicators (e.g. low lymphocyte count, pulmonary infiltrates, cardiac symptoms) associated with COVID-19 infection. There is no data to suggest the prothrombotic tendency of severe COVID-19 infection is also present in patients affected with relatively mild symptoms to our knowledge. A recently published case report of a nonagenarian with non-specific symptoms of low grade pyrexia, delirium (similar to Case C reported here) and abdominal pain diagnosed by post-mortem nasopharyngeal swab serves to emphasise the unpredictable nature of the COVID-19 syndrome as it affects our population ([@CR20]). Thus our understanding will continue to unfold with increased experience especially in older frail patients. Allowing for the novel nature of COVID-19, prospective alertness to new symptoms and complications such as thromboembolic disease in those COVID-19 patients affected by milder symptoms is merited.

Secondly, these may indeed be true negative swab results and in the absence of clinical improvement following treatment of other conditions in very frail older patients without COVID-19 infection, D-dimer testing may be appropriate and subsequent specific testing for VTE if elevated significantly. Further studies specifically in this frail population would be necessary to establish if such an approach is beneficial.
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